| MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application (NCT05979285) | Cumbria Partnership NHS Foundation Trust | 2020-10-15 |
| Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab (NCT04592952) | Danish Headache Center | 2020-10-08 |
| A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist (NCT04294147) | Eli Lilly and Company | 2020-10-06 |
| Validation of a Questionnaire for Allodynia in Migraine. (NCT04580641) | University Hospital, Clermont-Ferrand | 2020-10-01 |
| Registry for Migraine - Clinical Core (NCT04603976) | Danish Headache Center | 2020-09-25 |
| A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age (NCT04464707) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-09-24 |
| miR-155 Expression in Episodic and Chronic Migraine (NCT05891808) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2020-09-22 |
| A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents (NCT04530110) | Teva Branded Pharmaceutical Products R&D LLC | 2020-09-16 |
| Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine (NCT04252742) | Amgen | 2020-09-15 |
| Telehealth Behavioral Migraine Management (NCT03982316) | Albert Einstein College of Medicine | 2020-09-15 |
| Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment (NCT05199064) | Tepecik Training and Research Hospital | 2020-09-15 |
| Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data (NCT05177406) | Novartis Pharmaceuticals | 2020-08-31 |
| Natural Language Processing for Headache Medicine (NCT05377437) | University Hospital, Ghent | 2020-08-28 |
| Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants (NCT04492020) | AbbVie | 2020-08-21 |
| A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab (NCT04537429) | H. Lundbeck A/S | 2020-08-04 |
| The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients (NCT04452929) | Danish Headache Center | 2020-07-22 |
| A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age (NCT04458857) | Teva Branded Pharmaceutical Products R&D, Inc. | 2020-07-15 |
| Prescription of Triptans in the Grand Est Region, France (NCT05780580) | Centre Hospitalier Régional Metz-Thionville | 2020-07-15 |
| Changes and Associations Between Cervical Range of Motion, Pain, TMJ Range of Motion and Quality of Life in Migraineurs Applying Physical Therapy (NCT04729699) | Lithuanian University of Health Sciences | 2020-07-13 |
| Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities. (NCT05375097) | Novartis Pharmaceuticals | 2020-07-03 |
| The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects (NCT04401137) | SK Chemicals Co., Ltd. | 2020-07-01 |
| Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache (NCT04949204) | University Hospital, Ghent | 2020-07-01 |
| A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (NCT04396574) | Eli Lilly and Company | 2020-06-30 |
| A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients (NCT04355117) | Otsuka Pharmaceutical Co., Ltd. | 2020-06-17 |
| A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (NCT04396236) | Eli Lilly and Company | 2020-06-15 |
| A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (NCT04418765) | H. Lundbeck A/S | 2020-06-01 |
| The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients (NCT04260035) | Danish Headache Center | 2020-05-19 |
| Outcomes of Migraine Surgery (NCT04008303) | Vanderbilt University Medical Center | 2020-05-01 |
| Improved Treatment Course for Patients With Migraine and Tension-type Headache (NCT05278325) | Danish Headache Center | 2020-05-01 |
| Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression (NCT04912752) | University of Gaziantep | 2020-04-05 |
| Familial and Environmental Factors Behind Migraine (NCT04356079) | Assiut University | 2020-04-01 |
| Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study (NCT04299958) | Hospital Clínico Universitario de Valladolid | 2020-04-01 |
| Improvement of Migraine Severity and Frequency With Migraineguard ™ (NCT04759040) | Herbacure Natural | 2020-04-01 |
| Transcranial Direct Current Stimulation Associated With Mindfulness in Chronic Migraine (NCT04219345) | Federal University of Paraíba | 2020-03-30 |
| Probiotics for the Prophylaxis of Migraine (NCT04305522) | Biopolis S.L. | 2020-03-02 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches (NCT04211454) | ProgenaBiome | 2020-03-02 |
| Th Effect of Ketogenic Metabolic Nutritional Pattern on High-frequency Episodic Migraine (EMIKETO) (NCT04360148) | New Penta SRL | 2020-02-06 |
| CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study (NCT04138316) | Hospital Clínico Universitario de Valladolid | 2020-01-02 |
| THE EFFECTS OF KINESIO®TAPING IN PATIENTS WITH MIGRAINE (NCT04185714) | Medipol University | 2020-01-01 |
| Dexamethasone for Migraine - Dose Comparison (NCT04112823) | Montefiore Medical Center | 2019-12-22 |
| Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine (NCT03912337) | Amgen | 2019-12-04 |
| A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine (NCT04152083) | H. Lundbeck A/S | 2019-11-07 |
| Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly (NCT04803513) | Campus Bio-Medico University | 2019-11-01 |
| Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS) (NCT05785988) | Hospital Clínico Universitario de Valladolid | 2019-11-01 |
| Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab (NCT04114630) | Novartis Pharmaceuticals | 2019-10-30 |
| Default Mode Network Connectivity and Nocebo Responses in Migraine: A Functional MRI Study (NCT07720895) | Ioanna Spanou | 2019-10-22 |
| Single Ascending Dose Study to Investigate the Safety and Pharmacokinetics of XC101-D13H in Healthy Adult Subjects (NCT04104399) | Xoc Pharmaceuticals | 2019-10-08 |
| Initiating Early Control of Migraine Pain and Associated Symptoms (NCT04163185) | Axsome Therapeutics, Inc. | 2019-10-08 |
| Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study (NCT04084314) | Novartis Pharmaceuticals | 2019-09-30 |
| Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman (NCT04197349) | H. Lundbeck A/S | 2019-09-24 |
| A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder (NCT04041284) | Teva Branded Pharmaceutical Products R&D, Inc. | 2019-09-13 |
| Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine (NCT04007874) | Leiden University Medical Center | 2019-09-10 |
| Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma (NCT04196933) | Massachusetts Eye and Ear Infirmary | 2019-09-05 |
| Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients (NCT03867201) | Novartis Pharmaceuticals | 2019-08-26 |
| Vagus Nerve Stimulation and Stress Reduction Training for Migraine (NCT03592329) | Massachusetts General Hospital | 2019-08-20 |
| Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy (NCT04090333) | Danish Headache Center | 2019-08-01 |
| A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine (NCT03988088) | Eli Lilly and Company | 2019-07-22 |
| Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine (NCT03836040) | Amgen | 2019-07-19 |
| Objectively Diagnose and Monitor Treatment of Light Sensitivity (NCT03694626) | Randy Kardon | 2019-07-11 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients (NCT04012047) | Danish Headache Center | 2019-07-09 |
| Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) (NCT04068051) | Axsome Therapeutics, Inc. | 2019-07-06 |
| Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline (NCT04509141) | Indonesia University | 2019-07-05 |
| Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department (NCT04281030) | NYU Langone Health | 2019-06-30 |
| Trigeminal Brainstem Mapping (NCT03999060) | Universitätsklinikum Hamburg-Eppendorf | 2019-06-28 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (NCT03901482) | Satsuma Pharmaceuticals, Inc. | 2019-06-24 |
| A Study of Lasmiditan (LY573144) Over Four Migraine Attacks (NCT03670810) | Eli Lilly and Company | 2019-06-24 |
| Heartmath Migraine Study (NCT04077658) | NYU Langone Health | 2019-06-16 |
| Clinical Decision Support for Patient Migraine Management (NCT03706794) | Albert Einstein College of Medicine | 2019-06-05 |
| A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine (NCT03962738) | Eli Lilly and Company | 2019-05-31 |
| A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers (NCT03978403) | Zosano Pharma Corporation | 2019-05-29 |
| A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL) (NCT03787238) | ElectroCore INC | 2019-05-15 |
| Transcranial Magnetic Stimulation in Episodic Migraine (Magnet-EM) (NCT03556722) | Universiti Putra Malaysia | 2019-04-15 |
| A Controlled Trial of Erenumab in Migraine Prevention (NCT03812224) | Amgen | 2019-04-12 |
| PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine (NCT04413110) | Mansoura University Hospital | 2019-04-01 |
| Acute Treatment Trial in Adult Subjects With Migraines (NCT03872453) | Pfizer | 2019-03-25 |
| Imaging the Migraine Brain Pre- and Post-Erenumab (NCT03773562) | Mayo Clinic | 2019-03-25 |
| Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses. (NCT03902496) | Avulux, Inc. | 2019-03-18 |
| Maximizing Outcomes in Treating Acute Migraine (NCT03896009) | Axsome Therapeutics, Inc. | 2019-03-04 |
| Efficacy of Individualized Homeopathic Remedies on Migraine: a Randomized, Triple-blind, Placebo Controlled Study. (NCT05468801) | Hospital General de Agudos Bernardino Rivadavia | 2019-03-01 |
| Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine (NCT03712917) | Ataturk University | 2019-03-01 |
| Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine (NCT03828539) | Novartis Pharmaceuticals | 2019-02-22 |
| Sphenopalatine Ganglion Blocks RCT (NCT03666663) | University of California, San Francisco | 2019-02-01 |
| A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain (NCT03877718) | Charleston Laboratories, Inc | 2019-02-01 |
| Neurophysiology of Prophylactic Treatment in Migraine (NCT04019496) | University Medicine Greifswald | 2019-01-29 |
| Study of Pediatric Migraine: The Pediatric Migraine Registry (NCT03742024) | Duke University | 2018-12-05 |
| Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment (NCT05442008) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2018-12-01 |
| Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults (NCT03732638) | Pfizer | 2018-11-14 |
| Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department (NCT03576820) | New York City Health and Hospitals Corporation | 2018-10-15 |
| Mind and Body Approaches to Pain Reduction in Youth With Migraine (NCT03472092) | Children's Hospital Medical Center, Cincinnati | 2018-10-02 |
| Trans-diagnostic Cognitive-behavioral Therapy for Treatment of Migraine (NCT03701477) | Isfahan University of Medical Sciences | 2018-10-01 |
| High School Start Time and Teen Migraine Frequency (NCT03766412) | University of California, San Francisco | 2018-10-01 |
| Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis Individuals (NCT03768830) | University of Rijeka | 2018-10-01 |
| Deep Phenotyping of Rosacea and Migraine (NCT03872050) | Danish Headache Center | 2018-09-14 |
| A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT03874832) | Satsuma Pharmaceuticals, Inc. | 2018-09-11 |
| Physiopathology, Diagnosis and Therapy of Primary Cephalalgia and Adaptive Disorders (NCT04696510) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2018-08-31 |
| A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine (NCT03559257) | Eli Lilly and Company | 2018-07-31 |
| Prediction of WMH in Migraine Using a BOLD-CVR Map (NCT03494673) | Samsung Medical Center | 2018-07-13 |
| Efficacy of Manual Therapy for the Treatment of Migraine. (NCT03555214) | University of Valencia | 2018-06-30 |
| Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine (NCT03799211) | NYU Langone Health | 2018-06-04 |